NFG
CRDF icon

Next Financial Group’s Cardiff Oncology CRDF Stock Holding History

Next Financial Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7
Closed -$2K – 1756
2016
Q1 		$2K Hold
7
– – ﹤0.01% 1526
2015
Q4 		$2K Hold
7
– – ﹤0.01% 1577
2015
Q3 		$2K Buy
+7
New +$3.66K ﹤0.01% 1605

Other funds holding CRDF

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Next Financial Group's CRDF Position: Q2 2016 in Review

Next Financial Group sold out of Cardiff Oncology (CRDF) in Q2 2016, closing a stake of 7 shares — an estimated $2K sold.

Next Financial Group first reported a position in CRDF in Q3 2015 and held it in 3 quarters. The position peaked at $2K in Q1 2016. 66 funds tracked by Wall St. Rank hold CRDF as of Q2 2016.

  • Next Financial Group reported no remaining Cardiff Oncology position as of Q2 2016 after selling out during the quarter.
  • Next Financial Group sold 7 Cardiff Oncology shares in Q2 2016, an estimated $2K.
  • Next Financial Group first reported a position in Cardiff Oncology in Q3 2015 and held it in 3 quarters.
  • Next Financial Group's Cardiff Oncology position peaked at $2K in Q1 2016.
  • 66 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2016.

Based on Next Financial Group's 13F filing for Q2 2016, filed 7 Jul 2016.